Innovation

GENETIC SELECTION SYSTEM FOR microRNA TARGET GENES

Southern Illinois University School of Medicine
posted on 09/21/2009

SIU School of Medicine is seeking entities interested in licensing a novel genetic selection system for determining microRNA target genes.

Suggested Uses

◘ Reagent for cancer/genetics research ◘ Creation of a miRNA gene/target library ◘ Rapid screening for cDNAs and miRNAs of interest with clear, measurable results

Advantages

◘ High throughput ◘ Ease of use ◘ Measurable results ◘ No reliance on variable computer-based software for target prediction

Innovation Details
 

Detailed Description

miRNA target determination largely relies on computer-aided algorithms based on the nucleotide base pairing of a miRNA sequence and the 3’-untranslated regions of a potential target gene. However, predicted targets vary from one program to another. Recent evidence also indicates that even perfect base pairing may not predict miRNA-target interactions. This novel system utilizes a specially constructed plasmid that contains a puromycin resistance gene, a resistance gene blocker, and cDNA for a gene of interest. The plasmid is transfected into host cells along with a vector expressing a miRNA. If the cDNA contains a miRNA target, the cells will live in the presence of puromycin. If the cDNA does not contain a miRNA target, the cells will die in the presence of puromycin. This method can be used with cDNAs and miRNAs of interest as a rapid screening tool that provides clear and measurable results. This invention could be sold either as individual plasmids or a kit and would save researchers weeks to months performing individual target validation tests.

File Number: 2.189.121 

Other Information: Current work is focused on optimizing the experimental system to create greater reliability and reduce the number of false positives. ***This technology incorporates proprietary materials controlled by Tet Systems GmbH & Co. KG. Additional permissions and commercialization rights from Tet Systems may be required to market this technology.***


IP Protection

Patent Number(s): 12/258016

License Online

This innovation currently is not available for online licensing. Please contact Robert Patino at Southern Illinois University School of Medicine for more information.

Request more info via email request more info
People

Principal Investigator:

Yin-Yuan  Mo Yin-Yuan Mo

Innovations (1)

Publications (7)


Case Manager:

Robert Patino Robert Patino

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,805 members 16,684 innovations 159 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...